首页> 外文期刊>Lipids in Health Disease >Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells
【24h】

Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells

机译:调节载脂蛋白M表达的二氢睾丸激素通过蛋白激酶C介导HepG2细胞

获取原文
获取外文期刊封面目录资料

摘要

Background Administration of androgens decreases plasma concentrations of high-density lipid cholesterol (HDL-C). However, the mechanisms by which androgens mediate lipid metabolism remain unknown. This present study used HepG2 cell cultures and ovariectomized C57BL/6 J mice to determine whether apolipoprotein M (ApoM), a constituent of HDL, was affected by dihydrotestosterone (DHT). Methods HepG2 cells were cultured in the presence of either DHT, agonist of protein kinase C (PKC), phorbol-12-myristate-13-acetate (PMA), blocker of androgen receptor flutamide together with different concentrations of DHT, or DHT together with staurosporine at different concentrations for 24 hrs. Ovariectomized C57BL/6 J mice were treated with DHT or vehicle for 7d or 14d and the levels of plasma ApoM and livers ApoM mRNA were measured. The mRNA levels of ApoM, ApoAI were determined by real-time RT-PCR. ApoM and ApoAI were determined by western blotting analysis. Results Addition of DHT to cell culture medium selectively down-regulated ApoM mRNA expression and ApoM secretion in a dose-dependent manner. At 10 nM DHT, the ApoM mRNA levels were about 20% lower than in untreated cells and about 40% lower at 1000 nM DHT than in the control cells. The secretion of ApoM into the medium was reduced to a similar extent. The inhibitory effect of DHT on ApoM secretion was not blocked by the classical androgen receptor blocker flutamide but by an antagonist of PKC, Staurosporine. Agonist of PKC, PMA, also reduced ApoM. At 0.5 μM PMA, the ApoM mRNA levels and the secretion of ApoM into the medium were about 30% lower than in the control cells. The mRNA expression levels and secretion of another HDL-associated apolipoprotein AI (ApoAI) were not affected by DHT. The levels of plasma ApoM and liver ApoM mRNA of DHT-treated C57BL/6 J mice were lower than those of vehicle-treated mice. Conclusions DHT directly and selectively down-regulated the level of ApoM mRNA and the secretion of ApoM by protein kinase C but independently of the classical androgen receptor.
机译:背景雄激素的给药降低了高密度脂质胆固醇(HDL-C)的血浆浓度。但是,雄激素介导脂质代谢的机制仍然未知。这项研究使用了HepG2细胞培养物和卵巢切除的C57BL / 6 J小鼠来确定载脂蛋白M(ApoM)是HDL的组成部分,是否受到二氢睾丸激素(DHT)的影响。方法在DHT,蛋白激酶C激动剂(PKC),phorbol-12-肉豆蔻酸13-乙酸盐(PMA),雄激素受体氟他胺阻断剂与不同浓度的DHT或DHT混合存在下培养HepG2细胞星形孢菌素以不同浓度持续24小时。将卵巢切除的C57BL / 6 J小鼠用DHT或溶媒处理7天或14天,并测量血浆ApoM和肝脏ApoM mRNA的水平。通过实时RT-PCR测定ApoM,ApoAI的mRNA水平。通过蛋白质印迹分析确定ApoM和ApoAI。结果向细胞培养基中添加DHT以剂量依赖性方式选择性下调ApoM mRNA表达和ApoM分泌。在10 nM DHT下,ApoM mRNA水平比未处理细胞低约20%,在1000 nM DHT下比对照细胞低约40%。 ApoM向培养基中的分泌减少了相似的程度。 DHT对ApoM分泌的抑制作用不是被经典的雄激素受体阻滞剂氟他胺所阻断,而是被PKC的拮抗剂Staurosporine所阻断。 PKC的激动剂PMA也降低了ApoM。在0.5μMPMA下,ApoM mRNA水平和ApoM向培养基中的分泌比对照细胞低约30%。 DHT不影响另一种与HDL相关的载脂蛋白AI(ApoAI)的mRNA表达水平和分泌。 DHT处理的C57BL / 6 J小鼠的血浆ApoM和肝ApoM mRNA的水平低于媒介物处理的小鼠。结论DHT直接和选择性下调蛋白激酶C的ApoM mRNA水平和ApoM分泌,但与经典的雄激素受体无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号